ASRT Assertio Holdings Inc.

Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024

Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024

LAKE FOREST, Ill., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief Financial Officer, will host investor meetings at two investor conferences taking place in New York City during September 10-12, 2024.

Assertio will participate in the HC Wainwright Conference, which will take place September 10-11, 2024 at the Lotte New York Palace Hotel. Investors can register and request meetings via their HC Wainwright representative.

The Company will also participate in the Lake Street Capital Markets BIG8 Conference, taking place September 12, 2024 at the Yale Club. Investors can register and request meetings through their Lake Street representative.

About Assertio

Assertio is a commercial pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients. We have built our commercial portfolio through acquisition or licensing of approved products. Our commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting, and trade and distribution. To learn more about Assertio, visit . 

Investor Contact

Matt Kreps, Managing Director

Darrow Associates

M: 214-597-8200



EN
03/09/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Assertio Holdings Inc.

 PRESS RELEASE

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing...

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) LAKE FOREST, Ill., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that effective October 1, 2024, the Compensation Committee of the Company’s Board of Directors granted two newly-hired employees a total of 16,325 restricted stock units (“RSUs”) and 24,670 stock options (“options”). The RSUs and options were granted as induc...

 PRESS RELEASE

Assertio to Participate in the HC Wainwright and Lake Street Conferenc...

Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024 LAKE FOREST, Ill., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief Financial Officer, will host investor meetings at two investor conferences taking place in New York City during September 10-12, 2024. Assertio will participate in the HC Wainwright Conference, which will take...

 PRESS RELEASE

Assertio Reports Second Quarter 2024 Financial Results

Assertio Reports Second Quarter 2024 Financial Results Second Quarter Total Net Product Sales of $30.7 Million Rolvedon Growth Continues, with $15.1 million in Net Product Sales $7.4 Million in Cash Flow from Operations, Cash and Short-Term Investments Increases to $88.4 Million LAKE FOREST, Ill., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today reported financial results for the second quarter ended June 30, 20...

 PRESS RELEASE

Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Result...

Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024 LAKE FOREST, Ill., July 24, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that it will release second quarter 2024 financial results on Wednesday, August 7, 2024, after the market close. Following the release of its financial results, Assertio’s management will host a live webcast of the earnings conference call at 4:30 p.m....

 PRESS RELEASE

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing...

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) LAKE FOREST, Ill., July 09, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that effective July 1, 2024, the Compensation Committee of the Company’s Board of Directors granted four newly-hired employees a total of 44,575 restricted stock units (“RSUs”) and 142,910 stock options (“options”). The RSUs and options were granted as inducem...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch